Physiological Effects of High-Flow Tracheal Oxygen Via An Modified Interface
NCT ID: NCT03244761
Last Updated: 2018-02-12
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
20 participants
OBSERVATIONAL
2017-07-01
2018-02-05
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Comparison of Physiological Effects of Two Types of High-Flow Oxygen Therapy in Tracheostomized Patients
NCT06816745
Early Non-invasive Ventilation and Progressive High Flow Oxygen Therapy Through Tracheostomy Tube Weaning Protocol in Tracheostomized Patients with Prolonged Mechanical Ventilation
NCT06642714
The Effect of High Flow Oxygen Therapy Via Tracheostomy on Diaphragm Function
NCT04758910
HFTO Via Tracheal Intubation in Neurocritical Patients
NCT07257016
Hemodynamic Responses to Ventilator Hyperinflation Technique
NCT02739841
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
CASE_CROSSOVER
PROSPECTIVE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
The standard HFT
The high-flow oxygen was delivered via tracheostomy using a standard HFT.
No interventions assigned to this group
The modified HFT
The high-flow oxygen was delivered via tracheostomy using a modified HFT.
The modified HFT
The HFT was modified by increasing the expiratory resistance.
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
The modified HFT
The HFT was modified by increasing the expiratory resistance.
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
Exclusion Criteria
* history of esophageal, gastric or lung surgery;
* The contraindication of using EIT (pacemaker, defibrillator, and implantable pumps).
18 Years
80 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Capital Medical University
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Jian-Xin Zhou
Professor
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Jian-Xin Zhou, MD
Role: PRINCIPAL_INVESTIGATOR
Beijing Tiantan Hospital
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Jian-Xin Zhou
Beijing, Beijing Municipality, China
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
KY-2017-CC-13
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.